Cutaneous necrosis as a result of isosulphane blue injection in mammarian sentinel lymph node mapping: report of two cases.

about

Cutaneous necrosis as a result of isosulphane blue injection in mammarian sentinel lymph node mapping: report of two cases.

Item

http://www.wikidata.org/entity/Q42790944

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cutaneous necrosis as a result ...... mapping: report of two cases.

@en

Cutaneous necrosis as a result ...... mapping: report of two cases.

@nl

type

Item

label

Cutaneous necrosis as a result ...... mapping: report of two cases.

@en

Cutaneous necrosis as a result ...... mapping: report of two cases.

@nl

prefLabel

Cutaneous necrosis as a result ...... mapping: report of two cases.

@en

Cutaneous necrosis as a result ...... mapping: report of two cases.

@nl

P1476

Cutaneous necrosis as a result ...... mapping: report of two cases.

@en

P2093

Alp Demirag

http://www.w3.org/2001/XMLSchema#string

Bora Koc

http://www.w3.org/2001/XMLSchema#string

Huseyin Y Bircan

http://www.w3.org/2001/XMLSchema#string

Ozgur Kemik

http://www.w3.org/2001/XMLSchema#string

P2860

Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer

Evolving role of skin sparing mastectomy.

A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.

Breast reconstruction following nipple-sparing mastectomy: predictors of complications, reconstruction outcomes, and 5-year trends.

Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer.

Adverse skin lesions after methylene blue injections for sentinel lymph node localization.

Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001.

The sentinel node biopsy is a new standard of care for patients with early breast cancer.

Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.

Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.

P304

79-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4137/CCREP.S16784

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

U Ozçelik

P577

2014-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265344161

http://www.w3.org/2001/XMLSchema#string

P698

25187747

http://www.w3.org/2001/XMLSchema#string

P932

4133033

http://www.w3.org/2001/XMLSchema#string